Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Amortization of Deferred Charges: 2018-2020

Historic Amortization of Deferred Charges for Avidity Biosciences (RNA) over the last 3 years, with Dec 2020 value amounting to $29,000.

  • Avidity Biosciences' Amortization of Deferred Charges was N/A to $20,000 in Q2 2020 from the same period last year, while for Jun 2020 it was $70,000, marking a year-over-year change of. This contributed to the annual value of $29,000 for FY2020, which is 59.15% down from last year.
  • Avidity Biosciences' Amortization of Deferred Charges amounted to $29,000 in FY2020, which was down 59.15% from $71,000 recorded in FY2019.
  • In the past 5 years, Avidity Biosciences' Amortization of Deferred Charges ranged from a high of $73,000 in FY2018 and a low of $29,000 during FY2020.
  • Moreover, its 3-year median value for Amortization of Deferred Charges was $71,000 (2019), whereas its average is $57,667.
  • Data for Avidity Biosciences' Amortization of Deferred Charges shows a maximum YoY slumped of 59.15% (in 2020) over the last 5 years.
  • Avidity Biosciences' Amortization of Deferred Charges (Yearly) stood at $73,000 in 2018, then dropped by 2.74% to $71,000 in 2019, then tumbled by 59.15% to $29,000 in 2020.